The association of nerve growth factor with bone neoplasms is related to its high-affinity receptor TrkA, and the gene encoding TrkA, NTRK1, may undergo fusion mutations, resulting in sustained activation of downstream pathways (Yichao et al., 2024). Here, NGF is linked to bone neoplasm.